PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Follicular Dendritic Cell Sarcoma.

Abstract Follicular dendritic cell sarcoma is a rare tumor that typically arises within lymph nodes but can also occur extranodally. It is important to have a high index of suspicion, so follicular dendritic cell sarcoma is included in the differential diagnosis of a spindle cell neoplasm in the appropriate clinical and morphologic settings. When included in the differential diagnosis, immunohistochemistry is generally sufficient to substantiate the diagnosis of follicular dendritic cell sarcoma. In this review, we discuss the clinicopathologic features of follicular dendritic cell sarcoma, recent molecular and cytogenetic findings, prognosis, and current approaches to treatment.
PMID
Related Publications

Follicular dendritic cell sarcoma: a diagnostic challenge !

Follicular Dendritic Cell Sarcoma.

Follicular dendritic cell sarcoma of the tonsil.

Follicular Dendritic Cell Sarcoma of Appendix Presenting as Acute Appendicitis: An Exceptionally Rare Case Report.

Interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma: histopathological findings for differential diagnosis.

Authors

Mayor MeshTerms
Keywords
Journal Title archives of pathology & laboratory medicine
Publication Year Start




PMID- 28353378
OWN - NLM
STAT- MEDLINE
DA  - 20170329
DCOM- 20170418
LR  - 20170418
IS  - 1543-2165 (Electronic)
IS  - 0003-9985 (Linking)
VI  - 141
IP  - 4
DP  - 2017 Apr
TI  - Follicular Dendritic Cell Sarcoma.
PG  - 596-599
LID - 10.5858/arpa.2016-0126-RS [doi]
AB  - Follicular dendritic cell sarcoma is a rare tumor that typically arises within
      lymph nodes but can also occur extranodally. It is important to have a high index
      of suspicion, so follicular dendritic cell sarcoma is included in the
      differential diagnosis of a spindle cell neoplasm in the appropriate clinical and
      morphologic settings. When included in the differential diagnosis,
      immunohistochemistry is generally sufficient to substantiate the diagnosis of
      follicular dendritic cell sarcoma. In this review, we discuss the
      clinicopathologic features of follicular dendritic cell sarcoma, recent molecular
      and cytogenetic findings, prognosis, and current approaches to treatment.
FAU - Chen, Tiffany
AU  - Chen T
FAU - Gopal, Purva
AU  - Gopal P
AD  - From the University of Texas, Southwestern Medical School, Dallas (Ms Chen); and 
      the Department of Pathology, University of Texas, Southwestern Medical Center,
      Dallas (Dr Gopal).
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Arch Pathol Lab Med
JT  - Archives of pathology & laboratory medicine
JID - 7607091
RN  - 0 (Biomarkers, Tumor)
SB  - AIM
SB  - IM
MH  - Biomarkers, Tumor/genetics/*metabolism
MH  - Dendritic Cell Sarcoma, Follicular/*diagnosis/genetics/*metabolism
MH  - Diagnosis, Differential
MH  - Genetic Predisposition to Disease/genetics
MH  - Humans
MH  - Immunohistochemistry/*methods
MH  - Mutation
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
EDAT- 2017/03/30 06:00
MHDA- 2017/04/19 06:00
CRDT- 2017/03/30 06:00
AID - 10.5858/arpa.2016-0126-RS [doi]
PST - ppublish
SO  - Arch Pathol Lab Med. 2017 Apr;141(4):596-599. doi: 10.5858/arpa.2016-0126-RS.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>